Skip to content
StockMarketAgent
Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

ETR/OBCK stock hub

ETR/OBCK has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ETR/OBCKis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
3.8B
Deutsche Börse Xetra
Market data

Live price

Current market quote for this ticker.

Current price
ETR/OBCK
In the news

Latest news · ETR/OBCK

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E20.2
P25 12.3P50 15.7P75 20.2
Trailing P/E41.8
P25 16.4P50 20.9P75 30.4
ROE27.2
P25 -6.7P50 8.5P75 17.2
ROIC10.3
P25 -1.7P50 8.5P75 17.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ETR/OBCK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
167
Groups with data
11
Currency
EUR
Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Germany
Country code
DE
Employees
10,365
Employees Change
1,086%
Employees Change Percent
11.7
Enterprise value
EUR 4.9B
Exchange
Deutsche Börse Xetra
Financial currency
EUR
First seen
2026-05-10
Industry
Medical Instruments & Supplies
Isin
DE000BCK2223
Last refreshed
2026-05-10
Market cap
EUR 3.8B
Price
EUR 60
Price currency
EUR
Rev Per Employee
178,473.54x
Sector
Healthcare
Sic
3842
Symbol
etr/OBCK
Website
https://corporate.ottobock.com/en/home

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

12
MetricValue
Earnings Yield
2.39%
EV Earnings
52.92x
EV/EBIT
19.72x
EV/EBITDA
13.85x
EV/FCF
20.53x
EV/Sales
2.87x
FCF yield
6.16%
Forward P/E
20.15x
P/B ratio
9.15x
P/E ratio
41.82x
P/S ratio
2.27x
PEG ratio
1.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

17
MetricValue
EBIT Margin
14.55%
EBITDA Margin
18.18%
FCF margin
13.98%
Gross margin
53.04%
Gross Profit
EUR 898M
Gross Profit Growth
9.59%
Gross Profit Growth Q
-8.99%
Net Income
EUR 91.8M
Net Income Growth
96.36%
Net Income Growth Q
475.76%
Pretax Margin
8.98%
Profit Margin
5.42%
Profit Per Employee
EUR 9,677
ROCE
16.5
ROE
27.17
ROIC
10.32
Roic5y
5.37

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

6
MetricValue
FCF Growth
27.2%
FCF Growth Q
-39.65%
OCF Growth
21.29%
OCF Growth Q
-38.12%
Revenue Growth
5.42x
Revenue Growth Q
-10.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Assets
EUR 2.1B
Cash
EUR 85.3M
Current Assets
EUR 650.2M
Current Liabilities
EUR 585.9M
Debt
EUR 1.1B
Debt EBITDA
EUR 3.13
Debt Equity
EUR 2.62
Debt FCF
EUR 4.64
Equity
EUR 419.5M
Interest Coverage
3.68
Liabilities
EUR 1.7B
Long Term Assets
EUR 1.4B
Long Term Liabilities
EUR 1.1B
Net Cash
EUR -1B
Net Cash By Market Cap
EUR -26.35
Net Debt EBITDA
EUR 3.29
Net Debt Equity
EUR 2.41
Net Debt FCF
EUR 4.28
Tangible Book Value
EUR -445.9M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
1.11
Net Working Capital
EUR 173.7M
Quick ratio
0.55
Working Capital
EUR 64.3M
Working Capital Turnover
EUR 19.47

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Dividend per share
EUR 0.97
Dividend Yield
1.62%
Payout Ratio
16.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

29
MetricValue
50-day SMA
55.72
All Time High
76.35
All Time High Change
-21.41%
All Time High Date
2025-11-26
All Time Low
45.56
All Time Low Change
31.69%
All Time Low Date
2026-03-23
ATR
2.28
Beta1y
0.63
Ch YTD
-8.05
High
62.5
High52
76.35
High52 Date
2025-11-26
High52ch
-21.41%
Low
60
Low52
45.56
Low52 Date
2026-03-23
Low52ch
31.69%
Ma50ch
7.67%
RSI
57.64
RSI Monthly
0
RSI Weekly
47.77
Sharpe ratio
-0.57x
Sortino ratio
-0.65
Total Return
1.62%
Tr YTD
-8.05
Tr1m
15.16%
Tr1w
5.45%
Tr3m
-1.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

4
MetricValue
Operating Income
EUR 246.4M
Operating Income Growth
40.04
Operating Income Growth Q
-30.29
Operating margin
14.55

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
9,015,037%
Net Borrowing
-195,200,000
Shares Insiders
3.47%
Shares Institutions
3.68%
Shares Out
63,990,151

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

47
MetricValue
Adjusted FCF
EUR 236.6M
Average Volume
17,668.85x
CAPEX
EUR -112M
Ch1m
15.16
Ch1w
5.45
Ch3m
-1.4
Ch6m
-12.09
Change
-3.85%
Change From Open
-3.38
Close
62.4
Days Gap
-0.48
Depreciation Amortization
61,400,000
Dollar Volume
1,105,260
Earnings Date
2026-05-06
EBIT
EUR 246.4M
EBITDA
EUR 307.8M
F Score
4
FCF
EUR 236.6M
FCF EV Yield
4.87x
FCF Per Share
EUR 3.7
Financing CF
-172,200,000
Fiscal Year End
December
Founded
1,919
Goodwill
514,300,000
Income Tax
EUR 61.1M
Investing CF
-165,900,000
Is Primary Listing
1
Last Earnings Date
2026-05-06
Last Report Date
2026-03-31
Ma20
58.26
Ma20ch
2.99%
Net CF
8,600,000
Next Earnings Date
2026-08-13
Open
62.1
P FCF Ratio
16.23
P OCF Ratio
11.01
Position In Range
0
Ppne
433,700,000
Price Date
2026-05-08
Price EBITDA
EUR 12.47
Relative Volume
1.04x
Revenue
1,693,000,000x
Tax By Revenue
3.61x
Tax Rate
40.2%
Tr6m
-12.09%
Volume
18,421
Z Score
2.89
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

ETR/OBCK dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.6%
$0.97 annual per share
Payout ratio
+16.4%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
Annualized growth of the per-share dividend
Total shareholder yield
+1.6%
Dividend yield + buyback yield combined
Ownership

Who owns ETR/OBCK?

Insider, institutional, and short-interest positioning.

Institutional ownership
+3.7%
Share of float held by funds and institutions
Insider ownership
+3.5%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

ETR/OBCK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
57.6
Neutral momentum band
Price vs 200-day MA
n/a
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-0.57
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ETR/OBCK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/OBCK stock rating?

etr/OBCK is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/OBCK analysis?

The full report lives at /stocks/etr/OBCK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/OBCK?

The latest report frames etr/OBCK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/OBCK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.